急性心肌梗死后心室重构防治专家共识

[1] Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (01) : 15 - 26

[2] Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (10) : 1074 - 1082

[3] Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1077 - 1084

[4] Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function.[J].Adrija Hajra;Aditi Ujjawal;Karan Sud;Sandipan Chakraborty;Dhrubajyoti Bandyopadhyay.IJC Heart & Vasculature.2019,

[5] Rationale and methods of the Prospective Study of Biomarkers; Symptom Improvement; and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).[J].James L. Januzzi;Javed Butler;Emmanuel Fombu;Alan Maisel;Kevin McCague;Ileana L. Piña;Margaret F. Prescott;Jerome B. Riebman;Scott Solomon.American Heart Journal.2018,

[6] Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis..[J].Olivier Huttin;Stefano Coiro;Christine Selton-Suty;Yves Juillière;Erwan Donal;Julien Magne;Nicolas Sadoul;Faiez Zannad;Patrick Rossignol;Nicolas Girerd.PLoS ONE.2017, 12

[7] Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain [J]. ANNALS OF LABORATORY MEDICINE, 2017, 37 (02) : 137 - 146

[8] 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)..[J].Zamorano Jose Luis;Lancellotti Patrizio;Rodriguez Muñoz Daniel;Aboyans Victor;Asteggiano Riccardo;Galderisi Maurizio;Habib Gilbert;Lenihan Daniel J;Lip Gregory Y H;Lyon Alexander R;Lopez Fernandez Teresa;Mohty Dania;Piepoli Massimo F;Tama

[9] Left Ventricular Remodelling: A Problem in Search of Solutions [J]. EUROPEAN CARDIOLOGY REVIEW, 2016, 11 (01) : 29 - 35

[10] Cardiac remodelling and function with primary mitral valve insufficiency studied by magnetic resonance imaging [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2016, 17 (08) : 863 - 870

[1] Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (01) : 15 - 26

[2] Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (10) : 1074 - 1082

[3] Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1077 - 1084

[4] Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function.[J].Adrija Hajra;Aditi Ujjawal;Karan Sud;Sandipan Chakraborty;Dhrubajyoti Bandyopadhyay.IJC Heart & Vasculature.2019,

[5] Rationale and methods of the Prospective Study of Biomarkers; Symptom Improvement; and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).[J].James L. Januzzi;Javed Butler;Emmanuel Fombu;Alan Maisel;Kevin McCague;Ileana L. Piña;Margaret F. Prescott;Jerome B. Riebman;Scott Solomon.American Heart Journal.2018,

[6] Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis..[J].Olivier Huttin;Stefano Coiro;Christine Selton-Suty;Yves Juillière;Erwan Donal;Julien Magne;Nicolas Sadoul;Faiez Zannad;Patrick Rossignol;Nicolas Girerd.PLoS ONE.2017, 12

[7] Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain [J]. ANNALS OF LABORATORY MEDICINE, 2017, 37 (02) : 137 - 146

[8] 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)..[J].Zamorano Jose Luis;Lancellotti Patrizio;Rodriguez Muñoz Daniel;Aboyans Victor;Asteggiano Riccardo;Galderisi Maurizio;Habib Gilbert;Lenihan Daniel J;Lip Gregory Y H;Lyon Alexander R;Lopez Fernandez Teresa;Mohty Dania;Piepoli Massimo F;Tama

[9] Left Ventricular Remodelling: A Problem in Search of Solutions [J]. EUROPEAN CARDIOLOGY REVIEW, 2016, 11 (01) : 29 - 35

[10] Cardiac remodelling and function with primary mitral valve insufficiency studied by magnetic resonance imaging [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2016, 17 (08) : 863 - 870